Search Results for: Genetics

Wrinkles in pitch of celeb fav Augustinus Bader cream

Kris Jenner, Jennifer Aniston, Augustinus Bader cream

Many celebs seem to be into cosmetics called Augustinus Bader cream products that claim to do something related to stem cells. The brand is wildly expensive. What’s this all about? Augustinus Bader is both a person and a line of cosmetic products. The goal of today’s post is to fact-check the claims and products of the Augustinus …

Wrinkles in pitch of celeb fav Augustinus Bader cream Read More »

Grading my 2022 regenerative medicine predictions

stem-cell-crystal-ball-300x3001

It’s that time of year again when I grade my previous year’s predictions for the stem cell & regenerative medicine space. Overall, I did better than a typical year. I give the 2022 predictions an A- overall. This exercise can be kind of fun but also humbling. For example, I tend to be too optimistic …

Grading my 2022 regenerative medicine predictions Read More »

He Jiankui says he’s back in the lab after prison for CRISPR babies

He Jiankui

Earlier this year Chinese researcher He Jiankui finished his prison sentence. When I saw that news I wondered about the next chapter for him. It seems he’s already back in the lab doing genetics research. At least that’s according to a blog by He Jiankui himself. Can we trust that what he has written on his website is …

He Jiankui says he’s back in the lab after prison for CRISPR babies Read More »

What is Mastodon & why so far it’s a clunky alternative to Twitter

Mastodon

Lately it seems like something called Mastodon is on the minds of many a Twitter user. There is a wave of people tweeting “let’s dump Twitter and go to Mastodon now that Musk has taken over!” However, so far I don’t see Mastodon as a solid alternative to the admittedly annoyingly musky Twitter. I do …

What is Mastodon & why so far it’s a clunky alternative to Twitter Read More »

Weekly reads: death in CRISPR trial, sickle cell, nose picking & dementia, epilepsy

CRISPR gene editing

As both a scientist who works on stem cells, cancer, and CRISPR, and a research advocate I’ve been fortunate to meet many patient advocates over the years. Some have been participants in clinical trials themselves. Benefits & risks of clinical trial participation It is very sobering to find out that a clinical trial participant has …

Weekly reads: death in CRISPR trial, sickle cell, nose picking & dementia, epilepsy Read More »

Weekly reads: chimera cat vs. chimeric rat, cheap sequencing, more

Venus, cat chimera

When you are a stem cell biologist and especially if you do a blog, you sometimes run across very strange things like a chimera cat. In this case, I stumbled on the whole topic of chimeric cats because I was searching for info on chimeric rats on Google. Of course, I was. It’s kind of …

Weekly reads: chimera cat vs. chimeric rat, cheap sequencing, more Read More »

Paper sparks renewed interest in transdifferentiation & clinical potential

transdifferentiation, iOPCS

There was a time when I thought transdifferentiation based approaches might quickly move into clinical trials. Then things kind of cooled off. We didn’t see many papers reporting methods to transdifferentiate cells. I still think that this technology, sometimes called direct reprogramming, has major potential. A new paper on making human brain cells this way got …

Paper sparks renewed interest in transdifferentiation & clinical potential Read More »

Histone code series: H3K27me3 & H3K27ac functions & roles in diseases like DIPG

ASCL1 in K27M tumors, H3K27me3 loss

Histone proteins such as histone H3 are often popping up in science writing and news sometimes includes specific modified forms of H3 including one that we scientists call H3K27me3. What is in this article What is H3K27me3? | The histone code | H3K27ac and H3K27me3 function | H3K27 and human disease | References The goal of today’s post …

Histone code series: H3K27me3 & H3K27ac functions & roles in diseases like DIPG Read More »

In big shift Dr. Robert Lanza exits Astellas

Dr. Robert Lanza

The recent news of Vertex Pharma buying small stem cell biotech ViaCyte and Doug Melton moving to Vertex brought to mind an old stem cell biotech called Advanced Cell Technology (ACT) and its leader, stem cell biologist Dr. Robert Lanza. Years ago, big pharma firm Astellas bought ACT and Lanza moved to be a leader of regenerative …

In big shift Dr. Robert Lanza exits Astellas Read More »

Weekly reads: $1B Saudi anti-aging push, OCT4 necklace, cancer trial wows, coffee brain

Stem-Cells-Aging, anti-aging

I recently wrote about stem cell-related ideas for anti-aging and even cheating death, but there are of course other approaches including drugs like metformin. A new article outlines a massive research funding plan to tackle aging. Let’s start with that. Recommend reads including anti-aging Saudi Arabia plans to spend $1 billion a year discovering treatments to …

Weekly reads: $1B Saudi anti-aging push, OCT4 necklace, cancer trial wows, coffee brain Read More »